ORIGINAL RESEARCH
Accepted on 21 Mar 2025
Integrating multi-omics and experimental techniques to decode ubiquitinated protein modifications in hepatocellular carcinoma
doi 10.3389/fphar.2025.1545472
- Frontiers in Pharmacology
- Pharmacology of Anti-Cancer Drugs
- Research Topics
- Decoding the Epigenetic Landscape: Elucidating Cancer Pathology and Identifying Novel Therapeutic Targets
Decoding the Epigenetic Landscape: Elucidating Cancer Pathology and Identifying Novel Therapeutic Targets
5,673
Total downloads
18k
Total views and downloads
Articles
ORIGINAL RESEARCH
Published on 19 Mar 2025
The real-world analysis of adverse events with azacitidine: a pharmacovigilance study based on the FAERS and WHO-VigiAccess databases
doi 10.3389/fphar.2025.1555838
- 189 views
ORIGINAL RESEARCH
Published on 18 Mar 2025
Characteristic analysis of adverse reactions of histone deacetylase inhibitors based on WHO-VigiAccess
doi 10.3389/fphar.2025.1563797
- 193 views
ORIGINAL RESEARCH
Published on 19 Feb 2025
Integration of multi-omics profiling reveals an epigenetic-based molecular classification of lung adenocarcinoma: implications for drug sensitivity and immunotherapy response prediction
doi 10.3389/fphar.2025.1540477
- 430 views
ORIGINAL RESEARCH
Published on 18 Feb 2025
Exploring the role of epigenetic regulation in cancer prognosis with epigenetic score
doi 10.3389/fphar.2025.1538205
- 436 views
ORIGINAL RESEARCH
Published on 14 Feb 2025
Identification of potential diagnostic targets and therapeutic strategies for anoikis-related biomarkers in lung squamous cell carcinoma using machine learning and computational virtual screening
doi 10.3389/fphar.2025.1500968
- 517 views
ORIGINAL RESEARCH
Published on 29 Jan 2025
NCAPD3-mediated ferroptosis of 2,3,5,4’-Tetrahydroxystilbene-2-O-β-D-glucoside inhibits proliferation in T47D cells
doi 10.3389/fphar.2024.1531220
- 455 views
ORIGINAL RESEARCH
Published on 22 Jan 2025
Development and pan-cancer validation of an epigenetics-based random survival forest model for prognosis prediction and drug response in OS
doi 10.3389/fphar.2025.1529525
- 509 views
ORIGINAL RESEARCH
Published on 15 Jan 2025
Intratumor microbiome-derived butyrate promotes chemo-resistance in colorectal cancer
doi 10.3389/fphar.2024.1510851
- 776 views
- 1 citation
ORIGINAL RESEARCH
Published on 14 Jan 2025
DNA methylation inhibitors adverse reaction characteristic analysis: an analysis based on the European spontaneous adverse event reporting system
doi 10.3389/fphar.2024.1527903
- 443 views
ORIGINAL RESEARCH
Published on 13 Jan 2025
Integration of histone modification-based risk signature with drug sensitivity analysis reveals novel therapeutic strategies for lower-grade glioma
doi 10.3389/fphar.2024.1523779
- 630 views
ORIGINAL RESEARCH
Published on 21 Nov 2024
The role of epigenetic regulation in pancreatic ductal adenocarcinoma progression and drug response: an integrative genomic and pharmacological prognostic prediction model
doi 10.3389/fphar.2024.1498031
- 1,092 views
Published in
Frontiers in Pharmacology
Pharmacology of Anti-Cancer Drugs
Participating Journals
Frontiers in Oncology
- 3.5 impact factor
- 6.2 citescore